Farmacy

Jan 17 2018

Eton Pharmaceuticals Announces $20 Million Series A Financing, pharmaceuticals news.#Pharmaceuticals #news

Eton Pharmaceuticals Announces $20 Million Series A Financing Proceeds to support the development of Eton’s proprietary corticotropin product candidate, Peyronie’s Disease product candidate and other sterile injectable product candidates News provided by Jun 20, 2017, 16:01 ET Share this article CHICAGO and SAN DIEGO , June 20, 2017 /PRNewswire/ — Eton Pharmaceuticals, Inc., a spin-out company of Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), today announced it has entered into a definitive securities purchase agreement with various accredited investors, to raise gross proceeds of approximately $20 million in a private placement of preferred stock. The investor syndicate consists of a number of …

Jan 17 2018

Pharmaceuticals Stock Price, Share Price, Live BSE, pharmaceuticals news.#Pharmaceuticals #news

pharmaceuticals Indian Pharma sector has made rapid strides in both global and domestic market. But the growth pangs were severe for domestic players eyeing greater share of global pie. The slow down in generic approvals by USFDA, the payment problems witnessed in a few developing markets since the quarter ended December 2008 and accelerated genericisation and intense compe. more Indian Pharma sector has made rapid strides in both global and domestic market. But the growth pangs were severe for domestic players eyeing greater share of global pie. The slow down in generic approvals by USFDA, the payment problems witnessed in …

Jan 17 2018

New Jersey suing Purdue Pharma for fueling state’s opioid crisis – NY Daily News, pharma

New Jersey suing Purdue Pharma for fueling state’s opioid crisis with deceptive marketing strategy New Jersey is one of 11 states that are suing Perdu over deceptive marketing strategy that is feeding the nation’s opioid crisis. New Jersey on Tuesday sued Purdue Pharma LP, accusing the maker of the chronic pain medication OxyContin of fueling the state’s opioid crisis through deceptive marketing to doctors and patients, including the elderly and the “opioid-naive.” The state’s attorney general, Christopher Porrino, faulted what he called Purdue’s “almost inconceivable callousness and irresponsibility” in a decade-long campaign of downplaying the risks and exaggerating the benefits …

Jan 17 2018

Pharmaceutical industry news, articles, jobs, reports, advice and services, pharma marketing news.#Pharma #marketing #news

First Herceptin biosimilar cleared in Europe Ontruzant is approved for all the same indications as Roche s blockbuster EMA forges closer ties with HTA umbrella group Agrees joint work plan with the European Network for Health Technology Assessment Novartis’ orphan drug Tasigna wins EU expanded indication The CML medication can now treat paediatric patients Amsterdam picked to host the European Medicines Agency But regulator faces a challenging relocation project to depart from London Concordia accused of overcharging NHS for thyroid drug The pharma firm said to have abused its position within the UK market Sales news Research news The state …

Jan 17 2018

CBC News – New Jersey becomes latest state to sue Purdue Pharma over OxyContin, pharma

State attorney general says Purdue is in the “bull’s-eye” of blame for opioid epidemic Posted:Oct 31, 2017 2:13 PM ET Several states have sued Purdue Pharma, manufacturer of OxyContin, over allegations its marketing practices contributed to the opioid crisis. The company continued to deny the allegations on Tuesday, when New Jersey became the latest state to file a lawsuit. Douglas Healey/Associated Press Related Related Stories New Jersey filed a lawsuit Tuesday against the company that manufactures OxyContin, claiming a “direct link” between the state’s opioid crisis and the firm’s deceptive marketing practices. State Attorney General Christopher Porrino says the five-count …

Jan 15 2018

Pharmaceutical Manufacturing and Exports, Research and Development in Pharma, aurobindo pharma news.#Aurobindo #pharma #news

aurobindo pharma news THROUGH TRUST SINGLE PRODUCT FILED IN 25 COUNTRIES THROUGH GROWTH 40% TOPLINE GROWTH IN THE LAST 4 YEARS THROUGH PARTNERSHIP ASSOCIATED WITH THE UNO FOR DEVELOPMENT OF ARVS THROUGH CAPABILITY 4900 KL REACTION CAPABILITY, 55 TYPES OF REACTION AUROBINDO’S WORKFORCE IS MAKING TOMORROW POSSIBLE OVER 14500 EMPLOYEES FROM 26 COUNTRIES Aurobindo is one of the top API manufacturing companies.. Read More formulations Formulations One of the largest vertically in. Read More Custom Synthesis Custom Synthesis AuroSource is the Custom. Read More ARVs / HIVs We aim to achieve the goals for wider access. Read More PEPTIDES Auro …

Jan 11 2018

Humco, A Diversified Global Pharmaceutical Company, pharmaceutical company news.#Pharmaceutical #company #news

Impacting Lives Around the World Leaders in Innovation People Are Our Priority What’s New at Humco Quality Starts Here ABOUT We Help People Feel Better PRODUCTS New Anti-Wrinkle Topical Cream PRODUCTS Quality Bulk APIs Now Available RESPONSIBILITY State-of-the-Art Facilities SINCE 1872 A trusted name that can be counted on UNSURPASSED QUALITY Adhering to the highest standards to improve the quality of people’s lives WORKING AT HUMCO Hiring the best and brightest in the industry PARTNERS & SUPPLIERS Collaborating to produce groundbreaking solutions to complex issues

Jan 11 2018

News – Pharmaceutical Technology, pharmaceutical company news.#Pharmaceutical #company #news

pharmaceutical company news New research conducted by the University College London (UCL) and the London School of Hygiene & Tropical Medicine in the UK has revealed that gastric acid suppressant, lansoprazole, can be. UK CMA accuses Concordia of overcharging NHS for thyroid drug UK regulator Competition and Markets Authority (CMA) has provisionally found that Canadian drug company Concordia overcharged the National Health Service (NHS) for liothyronine tablets, a major treatment for thyroid. Pfizer and NCCN fund new projects to improve breast cancer care Pfizer Global Medical Grants, in collaboration with the National Comprehensive Cancer Network’s (NCCN) Oncology Research Programme (ORP), …

Jan 11 2018

PharmaTimes – in-depth news, features and insights for the pharmaceutical and healthcare sectors, pharmaceutical news

Web Exclusives Stopping antibiotic resistance This Antibiotic Awareness Week, Thomas Cueni, chair of the AMR Industry Alliance, gives some practical steps to stop one of the biggest medical threats in the world A new OECD gold standard for lethal injection drugs The latest developments in a controversial area of the pharma industry Harnessing patient communities Why online communities are so important to both patients and pharma Wish you were here? Why UK expats in former British colonies are not missing the NHS Magazine Patient Files: Ulcerative colitis Charlotte Guinea talks about her experiences with this invisible disease What science really …

Jan 11 2018

Pharmaceutical jobs, news, events, resources, pharmaceutical news today.#Pharmaceutical #news #today

The Latest Pharma Jobs, News and Events RiboBio and GE Healthcare enter into a Strategic Partnership for Oligonucleotide Drug Development and Manufacturing At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ( RiboBio ) and GE Healthcare Life Sciences ( GE ) held a strategic partnership signing ceremony. The strategic partnership agreement is aimed at establishing a deep alliance to jointly build Asia s largest oligonucleotide drug development and manufacturing facility in China. The goal of this partnership is to provide a total solution for oligonucleotide drug companies worldwide. . Dr. Biliang ( Bill …